HomeFPH • ASX
add
Fisher & Paykel Healthcare Corporatn Ltd
Previous close
$24.37
Day range
$24.10 - $24.48
Year range
$18.58 - $26.08
Market cap
15.64B NZD
Avg Volume
312.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NZE
Financials
Income Statement
Revenue
Net income
| (NZD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 401.85M | 16.38% |
Operating expense | 166.75M | 16.40% |
Net income | 53.65M | 11.89% |
Net profit margin | 13.35 | -3.89% |
Earnings per share | — | — |
EBITDA | 99.20M | 17.05% |
Effective tax rate | 23.68% | — |
Balance Sheet
Total assets
Total liabilities
| (NZD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.50M | 1.00% |
Total assets | 2.39B | 14.10% |
Total liabilities | 638.00M | 3.55% |
Total equity | 1.75B | — |
Shares outstanding | 582.01M | — |
Price to book | 8.10 | — |
Return on assets | 7.98% | — |
Return on capital | 9.19% | — |
Cash Flow
Net change in cash
| (NZD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | 53.65M | 11.89% |
Cash from operations | 78.25M | 8,136.84% |
Cash from investing | -137.75M | -466.36% |
Cash from financing | 33.00M | 161.40% |
Net change in cash | -26.10M | -119.33% |
Free cash flow | -63.33M | -1,601.19% |
About
Fisher & Paykel Healthcare Corporation Limited is a manufacturer, designer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. Based in New Zealand, their products and systems are sold in around 120 countries worldwide. FPH is primarily an exporting company, with just 1 percent of revenue coming from New Zealand sales. Wikipedia
Founded
1934
Headquarters
Website
Employees
6,420
